Brief: Spago Nanomedical Q3 Sales SEK 485 Thousand
Nov 06 (Reuters) - Spago Nanomedical Q3 net income SEK -8.763 million. * Q3 operating expenses SEK -10.65 million * Q3 adjusted EPS SEK -0.03
Recent news on Spago Nanomedical AB (publ)
See all newsBrief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose